Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Adoptive cell therapy of melanoma with autologous tumour infiltrating lymphocytes

Prof Inge Marie Svane - Herlev Hospital, Copenhagen University, Copenhagen, Denmark
Adoptive cell therapy of melanoma with autologous tumour infiltrating lymphocytes ( Prof Inge Marie Svane - Herlev Hospital, Copenhagen University, Copenhagen, Denmark )
25 Mar 2014

Multiple Myeloma Debate 2014: Recent advances in multiple myeloma

Dr Pieter Sonneveld, Prof Michele Cavo, Dr Jesus San Miguel and Dr Meletios Dimopoulos
Multiple Myeloma Debate 2014: Recent advances in multiple myeloma ( Dr Pieter Sonneveld, Prof Michele Cavo, Dr Jesus San Miguel and Dr Meletios Dimopoulos )
2 Feb 2014

New line of therapy for acute myeloid leukaemia

Dr David Taussig - Barts Cancer Institute, London, UK
New line of therapy for acute myeloid leukaemia ( Dr David  Taussig - Barts Cancer Institute, London, UK )
18 Dec 2013

Comment: Transplantation and short telomeres increase the risk of cognitive impairment

Dr Jeffrey Miller - University of Minnesota, Minneapolis, USA
Comment: Transplantation and short telomeres increase the risk of cognitive impairment ( Dr Jeffrey Miller - University of Minnesota, Minneapolis, USA )
17 Dec 2013

Equality of access to transplant for ethnic minority patients

Dr Robert Lown - Royal Marsden Hospital, London, UK
Equality of access to transplant for ethnic minority patients ( Dr Robert Lown - Royal Marsden Hospital, London, UK )
17 Dec 2013

Full-intensity transplantation and short telomeres increase risk of cognitive impairment after allogeneic haematopoietic cell transplantation

Dr Smita Bhatia - City of Hope National Medical Center, Duarte, USA
Full-intensity transplantation and short telomeres increase risk of cognitive impairment after allogeneic haematopoietic cell transplantation ( Dr Smita Bhatia - City of Hope National Medical Center, Duarte, USA )
13 Dec 2013

Chimeric antigen receptor produces complete responses and long-term persistence in children and adults relapsed, refractory ALL

Dr. Stephen A. Grupp - University of Pennsylvania, Philadelphia, USA
Chimeric antigen receptor produces complete responses and long-term persistence in children and adults relapsed, refractory ALL ( Dr. Stephen A. Grupp - University of Pennsylvania, Philadelphia, USA )
8 Dec 2013

Long-term functional persistence, B cell aplasia and anti-leukaemia efficacy in refractory B cell malignancies

Dr Michael Kalos - University of Pennsylvania, Philadelphia, USA
Long-term functional persistence, B cell aplasia and anti-leukaemia efficacy in refractory B cell malignancies ( Dr Michael Kalos - University of Pennsylvania, Philadelphia, USA )
8 Dec 2013

T cells engineered with chimeric antigen receptor targeting CD19 produce significant long-term persistence

Dr Stephen A. Grupp - University of Pennsylvania, Philadelphia, USA
T cells engineered with chimeric antigen receptor targeting CD19 produce significant long-term persistence ( Dr Stephen A. Grupp - University of Pennsylvania, Philadelphia, USA )
8 Dec 2013

Removal of alpha/beta T cells and of CD19 B cells in children With acute leukaemia

Dr Alice Bertaina - IRCCS Bambino Gesù Children's Hospital, Rome, Italy
Removal of alpha/beta  T cells and of CD19  B cells in children With acute leukaemia ( Dr Alice Bertaina - IRCCS Bambino Gesù Children's Hospital, Rome, Italy )
8 Dec 2013

Transplantation and short telomeres increase the risk of cognitive impairment

Dr Smita Bhatia - City of Hope National Medical Center, Duarte, California
Transplantation and short telomeres increase the risk of cognitive impairment ( Dr Smita Bhatia - City of Hope National Medical Center, Duarte, California )
8 Dec 2013

Donor-derived anti-CD19 chimeric-antigen-receptor-expressing T cells cause regression of malignancy

Dr James Kochenderfer - National Cancer Institute, Bethesda, USA
Donor-derived anti-CD19 chimeric-antigen-receptor-expressing T cells cause regression of malignancy ( Dr James Kochenderfer - National Cancer Institute, Bethesda, USA )
7 Dec 2013